Sree Rayalaseema Hi-Strength Hypo quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	211	180	+17.0%
EBITDA	29.9	27.9	+6.9%
EBITDA margin	14.2%	15.5%	−1.3 pts
Profit before tax	33.9	31.3	+8.2%
Net profit	24.7	22.4	+10.3%
EPS	₹14.53	₹13.06	+11.3%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	211	163	141	182	180	160	138	170	169	165	215	226	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	9.9	17.9	19.4	7.1	10.4	15.3	12.6	9.1	2.4	8.6	10.4	2.5
	221	181	161	189	191	176	151	179	171	174	225	228
	114	83.7	73.8	89.5	98.7	95.0	67.7	101	82.4	77.7	94.4	100.0
	0.0	0.0	0.0	0.0	0.0	−0.0	0.0	0.0	7.9	1.5	63.7	27.1
	−1.2	3.1	−2.6	−3.0	4.1	−4.7	7.2	−7.2	7.6	23.3	−10.7	16.4
	10.2	16.2	8.3	8.3	8.1	7.7	10.1	8.4	8.2	7.1	10.4	8.2
	0.5	0.4	0.4	0.4	0.4	0.7	0.4	0.3	0.6	2.1	0.6	0.6
	1.8	1.8	1.8	1.8	1.8	1.9	1.8	1.9	1.7	2.8	2.6	2.6
	58.1	46.8	41.5	60.6	41.4	44.9	33.7	39.0	36.8	28.6	34.7	47.7
	183	152	123	158	155	145	121	144	145	143	196	203
	29.9	13.3	20.3	27.0	27.9	17.6	19.8	28.9	25.7	27.0	22.2	26.2
	28.0	11.5	18.5	25.1	26.1	15.7	18.0	27.0	24.0	24.2	19.6	23.6
Profit
	37.4	29.0	37.5	31.8	36.1	30.4	30.2	35.8	25.9	30.7	29.3	25.4
	−3.5	−5.5	−3.2	0.0	−4.8	−3.1	0.0	0.0	0.0	−5.0	−5.9	0.0
	33.9	23.4	34.3	31.8	31.3	27.3	30.2	35.8	25.9	25.7	23.5	25.4
	8.8	3.7	10.1	8.1	8.4	4.5	8.5	9.1	6.9	5.9	6.6	6.9
	0.4	−0.3	0.4	0.4	0.5	0.8	0.1	1.4	0.3	0.3	0.2	0.0
	9.2	3.4	10.5	8.5	8.9	5.3	8.6	10.5	7.2	6.2	6.8	6.9
	24.7	20.1	23.7	23.3	22.4	22.0	21.6	25.3	18.6	19.5	16.6	18.5
	24.7	20.1	23.8	23.3	22.4	22.0	21.6	25.3	18.6	19.5	16.6	18.5
	−0.0	−0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	38.6	−58.3	−14.9	30.7	9.1	−15.2	20.8	13.9	13.6	−37.5	−14.3	24.6
	63.4	−38.3	8.8	54.0	31.5	6.8	42.3	39.2	32.2	−17.9	2.3	43.0
	25.0	—	—	23.3	—	—	—	—	—	—	—	—
	−0.2	—	—	0.0	—	—	—	—	—	—	—	—
Per share
	₹14.53	₹11.83	₹14.16	₹13.57	₹13.06	₹12.81	₹12.56	₹14.74	₹10.85	₹11.39	₹9.69	₹10.77
	₹14.53	₹11.83	₹14.16	₹13.57	₹13.06	₹12.81	₹12.56	₹14.74	₹10.85	₹11.39	₹9.69	₹10.77
Continuing & discontinued operations
	−0.0	−0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	−0.0	−0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other comprehensive income — detail
	38.6	−58.3	−14.9	30.7	9.1	−15.2	—	—	—	—	—	—
	51.6	−77.9	−19.9	41.1	12.2	−20.4	27.8	18.6	18.1	−50.0	−19.1	32.8
	13.0	−19.6	−5.0	10.3	3.1	−5.2	—	—	—	—	—	—
	—	—	—	—	—	—	7.0	4.7	4.6	−12.5	−4.8	8.3
	63.6	—	—	—	—	—	—	—	—	—	—	—
	−0.2	—	—	—	—	—	—	—	—	—	—	—
Per share — as-filed variants
	₹14.54	₹11.84	₹14.18	₹13.57	₹13.06	₹12.81	₹12.56	₹14.74	₹10.85	₹11.39	₹9.69	₹10.77
	₹14.54	₹11.84	₹14.18	₹13.57	₹13.06	₹12.81	₹12.56	₹14.74	₹10.85	₹11.39	₹9.69	₹10.77
	−₹0.01	−₹0.01	−₹0.02	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
	−₹0.01	−₹0.01	−₹0.02	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	98.1	76.3	70.0	95.8	77.4	70.2	63.6	76.4	70.7	62.6	67.2	82.1
	46.5%	46.8%	49.6%	52.5%	43.0%	43.7%	45.9%	44.9%	41.9%	37.9%	31.3%	36.4%
Adjusted (ex-exceptional items) — derived
	37.4	29.0	37.5	31.8	36.1	30.4	30.2	35.8	25.9	30.7	29.3	25.4
	−3.5	−5.5	−3.2	0.0	−4.8	−3.1	0.0	0.0	0.0	−5.0	−5.9	0.0
	27.3	24.8	26.0	23.3	25.8	24.5	21.6	25.3	18.6	23.3	20.8	18.5
	₹16.03	₹14.62	₹15.50	₹13.57	₹15.04	₹14.25	₹12.56	₹14.74	₹10.85	₹13.60	₹12.11	₹10.77

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SRHHYPOLTD₹473.25

Sree Rayalaseema Hi-Strength Hypo Limited

· Chemicals

Annual Quarterly₹ CrorePeersGEMAROMA DMCC SUDARCOLOR JAYAGROGN KRONOX AMNPLST CHEMFAB PRIMOMcap ₹812 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	225.5	214.5	165.2	168.6	170.2	138.5	160.5	180.3	182.4	141.2	163.1	210.9
Other Income	2.5	10.4	8.6	2.4	9.1	12.6	15.3	10.4	7.1	19.4	17.9	9.9
Total Income	228.0	224.9	173.8	171.1	179.4	151.0	175.8	190.6	189.5	160.6	181.0	220.8
Expenses
+ Cost of Materials Consumed	100.0	94.4	77.7	82.4	101.0	67.7	95.0	98.7	89.5	73.8	83.7	114.0
+ Purchases of Stock-in-Trade	27.1	63.7	1.5	7.9	0.0	0.0	-0.0	0.0	0.0	0.0	0.0	0.0
+ Changes in Inventories	16.4	-10.7	23.3	7.6	-7.2	7.2	-4.7	4.1	-3.0	-2.6	3.1	-1.2
+ Employee Benefit Expense	8.2	10.4	7.1	8.2	8.4	10.1	7.7	8.1	8.3	8.3	16.2	10.2
+ Finance Costs	0.6	0.6	2.1	0.6	0.3	0.4	0.7	0.4	0.4	0.4	0.4	0.5
+ Depreciation & Amortisation	2.6	2.6	2.8	1.7	1.9	1.8	1.9	1.8	1.8	1.8	1.8	1.8
+ Other Expenses	47.7	34.7	28.6	36.8	39.0	33.7	44.9	41.4	60.6	41.5	46.8	58.1
Total Expenses	202.5	195.6	143.1	145.2	143.5	120.9	145.4	154.6	157.7	123.1	152.1	183.4
EBITDA	26.2	22.2	27.0	25.7	28.9	19.8	17.6	27.9	27.0	20.3	13.3	29.9
EBIT	23.6	19.6	24.2	24.0	27.0	18.0	15.7	26.1	25.1	18.5	11.5	28.0
Profit
PBT before Exceptional Items	25.4	29.3	30.7	25.9	35.8	30.2	30.4	36.1	31.8	37.5	29.0	37.4
+ Exceptional Items	0.0	-5.9	-5.0	0.0	0.0	0.0	-3.1	-4.8	0.0	-3.2	-5.5	-3.5
Pretax Income	25.4	23.5	25.7	25.9	35.8	30.2	27.3	31.3	31.8	34.3	23.4	33.9
+ Current Tax	6.9	6.6	5.9	6.9	9.1	8.5	4.5	8.4	8.1	10.1	3.7	8.8
+ Deferred Tax	0.0	0.2	0.3	0.3	1.4	0.1	0.8	0.5	0.4	0.4	-0.3	0.4
Tax Expense	6.9	6.8	6.2	7.2	10.5	8.6	5.3	8.9	8.5	10.5	3.4	9.2
Net Income	18.5	16.6	19.5	18.6	25.3	21.6	22.0	22.4	23.3	23.7	20.1	24.7
+ Net Income — Continuing Ops	18.5	16.6	19.5	18.6	25.3	21.6	22.0	22.4	23.3	23.8	20.1	24.7
+ Net Income — Discontinued Ops	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.0	-0.0	-0.0
+ Other Comprehensive Income	24.6	-14.3	-37.5	13.6	13.9	20.8	-15.2	9.1	30.7	-14.9	-58.3	38.6
Total Comprehensive Income	43.0	2.3	-17.9	32.2	39.2	42.3	6.8	31.5	54.0	8.8	-38.3	63.4
Net Income to Common	—	—	—	—	—	—	—	—	23.3	—	—	25.0
Minority Interest	—	—	—	—	—	—	—	—	0.0	—	—	-0.2
Per Share
Basic EPS	10.77	9.69	11.39	10.85	14.74	12.56	12.81	13.06	13.57	14.16	11.83	14.53
Diluted EPS	10.77	9.69	11.39	10.85	14.74	12.56	12.81	13.06	13.57	14.16	11.83	14.53
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.0	-0.0	-0.0
+ Tax — Discontinued Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.0	-0.0	-0.0
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	-15.2	9.1	30.7	-14.9	-58.3	38.6
+ Items NOT to be Reclassified to P&L	32.8	-19.1	-50.0	18.1	18.6	27.8	-20.4	12.2	41.1	-19.9	-77.9	51.6
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	-5.2	3.1	10.3	-5.0	-19.6	13.0
+ Tax on Items NOT to be Reclassified — alt tag	8.3	-4.8	-12.5	4.6	4.7	7.0	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	—	—	—	—	—	—	—	—	—	—	—	63.6
Comprehensive Income — Non-controlling Interests	—	—	—	—	—	—	—	—	—	—	—	-0.2
Per Share — as-filed variants
Basic EPS — Continuing Operations	10.77	9.69	11.39	10.85	14.74	12.56	12.81	13.06	13.57	14.18	11.84	14.54
Diluted EPS — Continuing Operations	10.77	9.69	11.39	10.85	14.74	12.56	12.81	13.06	13.57	14.18	11.84	14.54
Basic EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	-0.01	-0.01
Diluted EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	-0.01	-0.01
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	82.1	67.2	62.6	70.7	76.4	63.6	70.2	77.4	95.8	70.0	76.3	98.1
Gross Margin %	36.40	31.32	37.92	41.92	44.85	45.91	43.72	42.96	52.52	49.60	46.76	46.53
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	25.4	29.3	30.7	25.9	35.8	30.2	30.4	36.1	31.8	37.5	29.0	37.4
− Exceptional Items (reconciliation)	0.0	-5.9	-5.0	0.0	0.0	0.0	-3.1	-4.8	0.0	-3.2	-5.5	-3.5
Net Income Adj (tax-effected)	18.5	20.8	23.3	18.6	25.3	21.6	24.5	25.8	23.3	26.0	24.8	27.3
EPS Adj	10.77	12.11	13.60	10.85	14.74	12.56	14.25	15.04	13.57	15.50	14.62	16.03
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	17.2	17.2	17.2	17.2	17.2	17.2	17.2	17.2	17.2	17.2	17.2	17.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Sree Rayalaseema Hi-Strength Hypo quarterly results

Sree Rayalaseema Hi-Strength Hypo (NSE: SRHHYPOLTD) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹25 crore, up 11.4% from ₹22.4 crore in Q1 FY26 and up 24.5% from ₹20.1 crore in Q4 FY26. Revenue from operations was ₹211 crore, up 17.0% year on year and up 29.3% from the previous quarter.

Q2 FY26 results (a year earlier): 13 November 2025
Q1 FY27 results (the latest): 12 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net profit: ₹25 Cr+11.4% vs Q1 FY26+24.5% vs Q4 FY26
Q1 FY27 revenue: ₹211 Cr+17.0% vs Q1 FY26+29.3% vs Q4 FY26
Q1 FY27 operating margin: 13.3%−1.2 pts vs Q1 FY26+6.3 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹23.3 CrRevenue ₹182 Cr
Q1 FY27 EPS (basic): ₹14.53

Questions

When will Sree Rayalaseema Hi-Strength Hypo announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33). Last year it reported Q2 FY26 on 13 November 2025.

What were Sree Rayalaseema Hi-Strength Hypo's Q1 FY27 results?

Consolidated net profit was ₹25 crore, up 11.4% from ₹22.4 crore in Q1 FY26 and up 24.5% from ₹20.1 crore in Q4 FY26. Revenue from operations was ₹211 crore, up 17.0% year on year and up 29.3% from the previous quarter.

What was Sree Rayalaseema Hi-Strength Hypo's net profit in FY26?

Consolidated net profit was ₹90.1 crore in FY26 (April 2025–March 2026), up 3.1% from ₹87.5 crore in FY25. It was ₹79 crore in FY24 and ₹154 crore in FY23: down 41.6% over three years, an average fall of 16.4% a year.

What will Sree Rayalaseema Hi-Strength Hypo's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹23.3 crore and revenue from operations ₹182 crore. The latest quarter, Q1 FY27, had a net profit of ₹25 crore and revenue of ₹211 crore.

How has Sree Rayalaseema Hi-Strength Hypo's profit changed over the last four quarters?

Net profit by quarter: ₹23.3 crore in Q2 FY26, ₹23.7 crore in Q3 FY26, ₹20.1 crore in Q4 FY26 and ₹25 crore in Q1 FY27. That is ₹92.1 crore over the four quarters, up 0.9% from ₹91.3 crore in the four quarters before. Revenue from operations: ₹182 crore, ₹141 crore, ₹163 crore and ₹211 crore.

What was Sree Rayalaseema Hi-Strength Hypo's revenue in FY26?

Revenue from operations was ₹667 crore in FY26 (April 2025–March 2026), up 4.6% from ₹638 crore in FY25. It was ₹866 crore in FY24 and ₹1,650 crore in FY23: down 59.6% over three years, an average fall of 26.1% a year.

Where do these Sree Rayalaseema Hi-Strength Hypo figures come from?

From Sree Rayalaseema Hi-Strength Hypo's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.